Clinical trial
Efficacy Study of ABR-215050 to Treat Prostate Cancer
NCT00560482
Study timeline
Study start (unknown)2007-12-01Date precision: month
Registry last updated2015-10-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
Active Biotech ABlead sponsor
Mapped research locations
San DiegoCalifornia, United States5New YorkNew York, United States2DenverColorado, United States2HoustonTexas, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1PittsburghPennsylvania, United States1DurhamNorth Carolina, United States1AlbuquerqueNew Mexico, United States1BuffaloNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00560482 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.